Gβ5-RGS complexes are gatekeepers of hyperactivity involved in control of multiple neurotransmitter systems. - Wikidata - awgldk - TriplyDB

Gβ5-RGS complexes are gatekeepers of hyperactivity involved in control of multiple neurotransmitter systems.

Gβ5-RGS complexes are gatekeepers of hyperactivity involved in control of multiple neurotransmitter systems.

http://www.wikidata.org/entity/Q35678190

about

G protein beta 5 is targeted to D2-dopamine receptor-containing biochemical compartments and blocks dopamine-dependent receptor internalization GNB5 mutation causes a novel neuropsychiatric disorder featuring attention deficit hyperactivity disorder, severely impaired language development and normal cognition Regulator of G protein signaling 6 (RGS6) protein ensures coordination of motor movement by modulating GABAB receptor signaling.Association of Rgs7/Gβ5 complexes with Girk channels and GABAB receptors in hippocampal CA1 pyramidal neurons.Ablation of the GNB3 gene in mice does not affect body weight, metabolism or blood pressure, but causes bradycardia.Regulator of G protein signaling 6 is a critical mediator of both reward-related behavioral and pathological responses to alcohol RGS proteins as targets in the treatment of intestinal inflammation and visceral pain: New insights and future perspectives Regulators of G protein signaling RGS7 and RGS11 determine the onset of the light response in ON bipolar neurons.The complex of G protein regulator RGS9-2 and Gβ(5) controls sensitization and signaling kinetics of type 5 adenylyl cyclase in the striatum Transgenic mouse models for ADHD.Cellular and Subcellular Localization of the RGS7/Gβ5/R7BP Complex in the Cerebellar Cortex Regulator of G-protein signaling Gβ5-R7 is a crucial activator of muscarinic M3 receptor-stimulated insulin secretion.Methylomic analysis of salivary DNA in childhood ADHD identifies altered DNA methylation in VIPR2.Exploring the Validity of Proposed Transgenic Animal Models of Attention-Deficit Hyperactivity Disorder (ADHD).A High-Throughput Time-Resolved Fluorescence Energy Transfer Assay to Screen for Modulators of RGS7/Gβ5/R7BP Complex.Increased store-operated Ca2+ entry mediated by GNB5 and STIM1.

P2860

Q28542580-9C140F67-0904-4D71-BFD2-D86DDA74EDD0 Q28975772-10DCDF55-2200-4E6A-8D72-2E7198139EB2 Q30505394-99931450-B0D3-4E0B-9260-CE524A5DF273 Q33768318-9740B48A-45F1-4F2F-B8C2-03C9FFE19A16 Q34160902-27FBC229-E7E6-41B7-9DA9-F71571358661 Q35129073-ED4384C6-A9AA-4D68-91AA-9AA2A41B1C60 Q35906057-240E7F19-8F01-4800-8F1C-D5CE43D3A9D7 Q35974073-7BFE0C26-C0D7-41CD-80E8-B243A6D59692 Q36634572-7A24E7DB-CB02-4DC6-92B1-E8082A99C2C1 Q37203801-5E095590-BEBF-4F28-884D-D5A6CADB7A24 Q37452610-EE7E959A-0F36-40A8-96FE-64058488258F Q38697839-D8941B78-3972-4DFB-BDA5-6A1824C10BB9 Q38971174-C6C908D4-3BBF-4E6E-BC6B-ED7296FD044B Q39324205-86A58269-B5D9-4EA7-8DBE-2F5DBC5FC1ED Q52320595-AE13E753-02D2-4894-ACC9-71384F6DC792 Q55085480-76D7B9A4-2827-4F21-BC41-29638FC4AA7C

P2860

Gβ5-RGS complexes are gatekeepers of hyperactivity involved in control of multiple neurotransmitter systems.

http://www.wikidata.org/entity/Q35678190

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Gβ5-RGS complexes are gatekeep ...... iple neurotransmitter systems.

@ast

Gβ5-RGS complexes are gatekeep ...... iple neurotransmitter systems.

@en

type

label

Gβ5-RGS complexes are gatekeep ...... iple neurotransmitter systems.

@ast

Gβ5-RGS complexes are gatekeep ...... iple neurotransmitter systems.

@en

prefLabel

Gβ5-RGS complexes are gatekeep ...... iple neurotransmitter systems.

@ast

Gβ5-RGS complexes are gatekeep ...... iple neurotransmitter systems.

@en

P1433

Q35678190-9E0299EF-AF07-48DD-B232-67313E67636E

P1476

Q35678190-8466E1F4-DC79-490F-BA35-DAF49FDBDCE1

P2093

Q35678190-3066C528-3986-4EDC-82F4-F2CC6BF8CC68

Q35678190-6AFFC0C3-7C5B-4D98-B11E-25D5A7F7FE9D

Q35678190-6C0B8F17-3AD0-4D63-AFC2-04E98B319C66

Q35678190-6F657B44-88EC-40B2-8A73-F844B5F102C9

Q35678190-93C7E08F-5E41-41F2-A55B-342C4B223DDA

Q35678190-AAC84EC8-9A0F-49B9-9AB2-C3AE36AA320D

Q35678190-BF79FAA2-11E6-4A57-AE3A-36ED04636B33

P2860

Q35678190-010AFDBA-18CF-4058-A7C0-711660427EB7

Q35678190-022B5950-E6C5-4049-9EE1-463FE9E36436

Q35678190-06216998-3851-412D-8A3A-B0D1BFE49CDC

Q35678190-0691BBEA-6DE4-45DE-8B37-E2B886A73D60

Q35678190-0A2C2C1A-453B-4E47-89D5-7B1B35AE3CCE

Q35678190-0F3636B3-E721-44A4-A2DB-35AF605613C0

Q35678190-10945A9F-F89F-4A7D-A6A4-1D988BBFC053

Q35678190-1245E4DF-AEE9-446F-BC9A-BF98CCCA3742

Q35678190-1DDCC73A-686D-492C-ABA6-302179458F9A

Q35678190-1EADBC0A-C14C-4ED5-8E52-6C6E90C729EF

P2888

Q35678190-51125E42-2133-494A-BE40-D9F483DACA26

P304

Q35678190-ED0D1EDC-BD03-4501-8D88-EFDD329B01D5

P31

Q35678190-999D286C-CDEE-4BAE-B5A0-00FD298AD305

P356

Q35678190-6DDA4648-C4C6-40FC-A871-17A6AE28EF9B

P433

Q35678190-C52D15AE-E8CD-43EA-BE4A-494922C8F2EA

P478

Q35678190-2C3B7C8A-0B42-4218-B84C-15AA06E0768A

P50

Q35678190-859180D3-D524-4772-9DB0-69DC381EFDF3

P577

Q35678190-7C266057-C832-45C4-A273-503283D01C58

P5875

Q35678190-88B0932C-5E52-4310-9F65-095DAB3FD9F6

P698

Q35678190-B8901606-3AD8-40ED-8F47-43F9BD16938F

P921

Q35678190-1ED0FBCF-E3C3-4AC8-B61D-680806FDC7B3

P932

Q35678190-32A7E08B-9F06-4C4B-84F1-4748451D0DDF

P356

S00213-011-2409-Y

P1433

Psychopharmacology

P1476

Gβ5-RGS complexes are gatekeep ...... iple neurotransmitter systems.

@en

P2093

Kenneth J Renner

http://www.w3.org/2001/XMLSchema#string

Keqiang Xie

http://www.w3.org/2001/XMLSchema#string

Kirill A Martemyanov

http://www.w3.org/2001/XMLSchema#string

Rafael Lujan

http://www.w3.org/2001/XMLSchema#string

Robert L Meisel

http://www.w3.org/2001/XMLSchema#string

Shencheng Ge

http://www.w3.org/2001/XMLSchema#string

Victoria E Collins

http://www.w3.org/2001/XMLSchema#string

P2860

Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter

Glutamatergic modulation of hyperactivity in mice lacking the dopamine transporter

Shared heritability of attention-deficit/hyperactivity disorder and autism spectrum disorder

The R7 RGS protein family: multi-subunit regulators of neuronal G protein signaling

Motor coordination deficits in mice lacking RGS9

Essential role for RGS9 in opiate action

Instability of GGL domain-containing RGS proteins in mice lacking the G protein beta-subunit Gbeta5

Crystal structure of the multifunctional Gβ5–RGS9 complex

Molecular mechanisms of ligand binding, signaling, and regulation within the superfamily of G-protein-coupled receptors: molecular modeling and mutagenesis approaches to receptor structure and function.

R7BP complexes with RGS9-2 and RGS7 in the striatum differentially control motor learning and locomotor responses to cocaine

P2888

s00213-011-2409-y

P304

823-834

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00213-011-2409-Y

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

219

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-07-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51499352

http://www.w3.org/2001/XMLSchema#string

P698

21766168

http://www.w3.org/2001/XMLSchema#string

P921

neurotransmitter

P932

3260372

http://www.w3.org/2001/XMLSchema#string